e-learning
resources
Berlin 2008
Monday, 06.10.2008
Cystic fibrosis: new mechanisms, monitoring and treatment tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Association between nitric oxide and clinical phenotype in children with CF
K. M. de Winter – de Groot, S. van Haren Noman, M. G. Slieker, J. Buwalda, C. K. van der Ent (Utrecht, Netherlands)
Source:
Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Session:
Cystic fibrosis: new mechanisms, monitoring and treatment tools
Session type:
E-Communication Session
Number:
2874
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. M. de Winter – de Groot, S. van Haren Noman, M. G. Slieker, J. Buwalda, C. K. van der Ent (Utrecht, Netherlands). Association between nitric oxide and clinical phenotype in children with CF. Eur Respir J 2008; 32: Suppl. 52, 2874
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Clinical correlates of alveolar nitric oxide in COPD
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Inflammatory patterns in asthmatic children based on the measurement of alveolar nitric oxide
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Exhaled nitric oxide reference values in healthy Tunisian adults
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Changes in nitric oxide production in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 190s
Year: 2006
The use of exhaled nitric oxide (NO) to categorize asthma phenotype and treatment in children - Results from National Hospital of Pediatrics
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
Alveolar nitric oxide and its role in asthma control assessment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Who are the children with increased faractional exhaled nitric oxide?
Source: Virtual Congress 2020 – Paediatric asthma
Year: 2020
Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Nasal nitric oxide
Source: Eur Respir Monogr 2010; 49: 71-81
Year: 2010
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Reference values for offline exhaled and nasal nitric oxide in healthy children
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020
Correlations between fractional exhaled nitric oxide and age and lung function in healthy Thai adults
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Base nitric oxide level in saliva in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 736s
Year: 2005
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
The accuracy of nasal nitric oxide testing in PCD diagnostics is population specific
Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia
Year: 2015
Changes in nitric oxide production in patients with bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 588s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept